Evidence map›Paper›PMID 27602354›Full record

ReviewFrontiers in medicine2016

Oral Vitamin B12 Replacement for the Treatment of Pernicious Anemia.

Catherine Qiu Hua Chan, Lian Leng Low, Kheng Hock Lee

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 70 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Vitamin BCMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2022
    Article
  12. Review
  13. Article
  14. Vitamin BNutrients · 2020
    Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Another indication for the use of oral vitamin B-12 supplementation.The American journal of clinical nutrition · 2018
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Catherine Qiu Hua ChanDepartment of Family Medicine and Continuing Care, Singapore General Hospital , Singapore.
Lian Leng LowDepartment of Family Medicine and Continuing Care, Singapore General Hospital, Singapore; Family Medicine, Duke-NUS Medical School, Singapore.
Kheng Hock LeeDepartment of Family Medicine and Continuing Care, Singapore General Hospital, Singapore; Family Medicine, Duke-NUS Medical School, Singapore.
Duke-NUS Medical School · SGSingapore General Hospital · SG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Many patients with pernicious anemia are treated with lifelong intramuscular (IM) vitamin B12 replacement. As early as the 1950s, there were studies suggesting that oral vitamin B12 replacement may provide adequate absorption. Nevertheless, oral vitamin B12 replacement in patients with pernicious anemia remains uncommon in clinical practice. The objective of this review is to provide an update on the effectiveness of oral vitamin B12 for the treatment of pernicious anemia, the recommended dosage, and the required frequency of laboratory test and clinical monitoring. Relevant articles were identified by PubMed search from January 1, 1980 to March 31, 2016 and through hand search of relevant reference articles. Two randomized controlled trials, three prospective papers, one systematic review, and three clinical reviews fulfilled our inclusion criteria. We found that oral vitamin B12 replacement at 1000 μg daily was adequate to replace vitamin B12 levels in patients with pernicious anemia. We conclude that oral vitamin B12 is an effective alternative to vitamin B12 IM injections. Patients should be offered this alternative after an informed discussion on the advantages and disadvantages of both treatment options.

Indexed as

cobalamincyanocobalaminmecobalaminoral vitamin B12pernicious anemia

Identifiers

PMID27602354
PMCPMC4993789
OpenAlexW2508642789

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.